120 related articles for article (PubMed ID: 9219625)
1. Effect of DV-7028, a novel serotonin 5-HT2 receptor antagonist on the cardiovascular system in rats.
Pawlak D; Małyszko J; Myśliwiec M; Takada A; Buczko W
Acta Physiol Hung; 1996; 84(3):325-6. PubMed ID: 9219625
[TBL] [Abstract][Full Text] [Related]
2. Vascular and cardiac effects of DV-7028, a selective, 5-HT2-receptor antagonist in rats.
Pawlak D; Adamkiewicz M; Malyszko J; Takada A; Mysliwiec M; Buczko W
J Cardiovasc Pharmacol; 1998 Aug; 32(2):266-73. PubMed ID: 9700989
[TBL] [Abstract][Full Text] [Related]
3. Influence of MCI-9042, a novel 5-HT2 receptor blocker on blood vessels of the rat.
Pawlak D; Małyszko J; Myśliwiec M; Takada A; Buczko W
Acta Physiol Hung; 1996; 84(3):323-4. PubMed ID: 9219624
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological profile of a new 5-hydroxytryptamine2 receptor antagonist, DV-7028.
Shibano T; Tanaka T; Morishima Y; Yasuoka M; Watanabe K; Fujii F
Arch Int Pharmacodyn Ther; 1992; 319():114-28. PubMed ID: 1285670
[TBL] [Abstract][Full Text] [Related]
5. Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats.
Kalkman HO; Engel G; Hoyer D
J Hypertens Suppl; 1984 Dec; 2(3):S143-5. PubMed ID: 6599662
[TBL] [Abstract][Full Text] [Related]
6. Influence of captopril on the serotonin-induced vasopressor effect in tail artery isolated from two-kidney, one-clip renal hypertensive rats.
Morelowska-Spierzak D; Pawlak D; Buczko W
Pol J Pharmacol; 1995; 47(5):417-22. PubMed ID: 8868133
[TBL] [Abstract][Full Text] [Related]
7. A potent 5-hydroxytryptamine receptor (5-HT2A) antagonist, DV-7028, delays arterial thrombosis development in rats.
Pawlak D; Pawlak K; Chabielska E; Małyszko J; Takada A; Myśliwiec M; Buczko W
Thromb Res; 1998 Jun; 90(6):259-70. PubMed ID: 9700856
[TBL] [Abstract][Full Text] [Related]
8. Influence of acetaldehyde on the vasopressor effect of serotonin in pithed rats.
Pawlak D; Krygicz D; Chabielska E; Buczko W
Alcohol Alcohol; 1992 Jul; 27(4):367-72. PubMed ID: 1418111
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular response to intravenous administration of 5-hydroxytryptamine after type-2 receptor blockade, by metrenperone, in healthy calves.
Linden A; Desmecht D; Amory H; Lekeux P
Vet J; 1999 Jan; 157(1):31-7. PubMed ID: 10030126
[TBL] [Abstract][Full Text] [Related]
10. WAY 405, a new silent 5-HT (1A) receptor antagonist with low affinity for vascular alpha (1)-adrenoceptors.
Villalobos-Molina R; Orozco-Méndez M; López-Guerrero JJ; Gallardo-Ortíz IA
Auton Autacoid Pharmacol; 2005 Oct; 25(4):185-9. PubMed ID: 16176451
[TBL] [Abstract][Full Text] [Related]
11. Vasodilator and vasoconstrictor responses induced by 5-hydroxytryptamine in the in situ blood autoperfused hindquarters of the anaesthetized rat.
Calama E; Fernández MM; Morán A; Martín ML; San Román L
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):110-6. PubMed ID: 12122496
[TBL] [Abstract][Full Text] [Related]
12. Influence of DAU 6215, a novel 5-HT3 receptor antagonist, on the cardiovascular system in anaesthetized and pithed rats.
Malinowska B; Pawlak D; Buczko W
Agents Actions; 1992 Jul; 36(3-4):230-6. PubMed ID: 1529806
[TBL] [Abstract][Full Text] [Related]
13. Interactions of minoxidil with vasoconstrictive agents in isolated rat tail artery.
Wasiński R; Godlewski G; Wróbel B; Buckzko W
Acta Pol Pharm; 1995; 52(3):253-6. PubMed ID: 8960256
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of Sida cordifolia leaves extract in rats.
Medeiros IA; Santos MR; Nascimento NM; Duarte JC
Fitoterapia; 2006 Jan; 77(1):19-27. PubMed ID: 16257496
[TBL] [Abstract][Full Text] [Related]
15. Characterization of contractile 5-hydroxytryptamine receptor subtypes in the in situ autoperfused kidney in the anaesthetized rat.
Morán A; Ortiz de Urbina AV; Martín ML; García M; Rodriguez-Barbero A; Dorado F; San Román L
Eur J Pharmacol; 2008 Sep; 592(1-3):133-7. PubMed ID: 18644367
[TBL] [Abstract][Full Text] [Related]
16. Serotonin-induced blood flow changes in the rat hindlegs after unilateral ligation of the femoral artery. Inhibition by the S2 receptor antagonist ketanserin.
Verheyen A; Vlaminckx E; Lauwers F; Van Den Broeck C; Wouters L
Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):280-98. PubMed ID: 6486974
[TBL] [Abstract][Full Text] [Related]
17. 5-HT activates vagal afferent cell bodies in vivo: role of 5-HT2 and 5-HT3 receptors.
Lacolley P; Owen JR; Sandock K; Lewis TH; Bates JN; Robertson TP; Lewis SJ
Neuroscience; 2006 Nov; 143(1):273-87. PubMed ID: 17029799
[TBL] [Abstract][Full Text] [Related]
18. Combined effect of the 5-HT2 receptor antagonist DV-7028 and aspirin or heparin on coronary cyclic flow reductions in dogs.
Tanaka T; Morishima Y; Watanabe K; Shibutani T; Yasuoka M; Shibano T
Cardiovasc Res; 1993 Jul; 27(7):1374-9. PubMed ID: 8252602
[TBL] [Abstract][Full Text] [Related]
19. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
Shaw LA; Batey AJ; Coker SJ
Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of acetaldehyde in pithed rats.
Pawlak D; Malinowska B; Buczko W
Pharmacology; 1992; 45(2):83-9. PubMed ID: 1523217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
